Nanoparticles simplify DNA identification and quantification
In an article published in Small, researchers successfully applied a new qualitative and quantitative method for the detection of a DNA sequence characteristic of Leishmania infantum kinetoplast, a frequent parasite in veterinary that affects humans too. The work was led from the Catalan Institute of Nanoscience and Nanotechnology (ICN2), a research Center placed in the Campus of the Autonomous University of Barcelona (UAB) in Bellaterra, and the UAB Spin Off company Vetgenomics.
This work was coordinated at ICN2 by ICREA Prof Arben Merkoçi, Leader of the ICN2 Nanobioelectronics & Biosensors Group, and Dr. Alfredo de la Escosura-Muñiz (first author of the article) with collaboration of Luis Pires, PhD student from the same group. The work was carried out in collaboration with Prof. Armand Sanchez, Dr. Olga Francino, Dr. Laura Altet and Lorena Serrano from Vetgenomics. Their results are part of the bio-applications defined in the ICN2 Severo Ochoa Program "Devices for Social Challenges". The present work has been published within the POC4PETS European Project, coordinated by the Alma Mater Studiorum - Università di Bologna (Italy) and aimed to improving the speed and accuracy of current diagnostics for veterinary pathogens.
Overcoming the classical PCR technique
The Polymerase Chain Reaction (PCR) is today's standard method to identify the presence of a specific DNA sequence in a sample. The PCR uses enzymes and two primers, strands of short nucleic acid sequences that serve as a starting point for DNA copy. When the detection is positive, this technique produces millions of copies of the problem sequence to facilitate its detection. This DNA amplification involves precise thermal changes (thermocycling) and sophisticate and expensive equipment which are overcome by an alternative approach called isothermal amplification, performed at constant temperature.
In this context, the authors of the article present a novel design of isothermal amplification using primers labelled with both gold nanoparticles and magnetic microbeads. The amplified product carries both labels allowing a rapid purification and quantification. The magnetic properties of the first primer facilitate the purification/preconcentration of the amplified DNA through magnetic separation methods. On the other hand, the gold nanoparticles are easily quantified by simple electrocatalytic detection methods. Thus, the use of primers labelled with gold nanoparticles and magnetic microbeads turns isothermal amplification into a faster and easier qualitative and quantitative diagnostic method.
Nanoparticles for Leishmania detection and other point-of-care tests
This approach was successfully applied for the detection of a DNA sequence characteristic of Leishmania infantum kinetoplast, a parasite responsible of a disease in domestic dogs, wild canids and humans. The electrochemical method exhibited a good reproducibility and sensitivity. Furthermore, amplified DNA from dogs without Leishmania was perfectly discriminated, demonstrating the specificity of both the amplification procedure and the electrochemical detection. In fact, the performance of the proposed approach is better than the obtained with other point-of-care tests for Leishmania detection, offering also a quantitative tool for parasite determination. This method represents a universal methodology that could be applied for any isothermal DNA amplification design.
Other news from the department science
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
